Trial intelligence / Profile preview

Teicoplanin pharmacokinetics during CVVH and albumin dialysis in critically ill adults

2005-000071-18Phase 4Completed

Sponsor
Medical University of South Carolina
Start
Mar 2005
Modality
Small Molecules
Countries
1
01

Overview

Phase 4, open-label trial of teicoplanin in bacterial disease and Staphylococcosis (2 cohorts), sponsored by Medical University of South Carolina. Primary endpoints: Maximum plasma concentration, Area under the concentration-time curve and 5 more. Started Mar 2005; status: completed.

02

Drugs

teicoplanin
03

Conditions

bacterial diseaseStaphylococcosis

Beyond the preview

Go deeper on 2005-000071-18.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on 2005-000071-18.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call